数据链接：
官方服务：
资源简介：
Frequency of adverse events by treatment group.
应用场景：
创建时间：
2020-03-16
相关数据集
Additional file 8 of Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies
Additional file 8: Table S1. Results of Begg’s adjusted rank correlation test and Egger’s test for adverse events.
DataCite Commons2024-02-07 更新60
Table_2_Comparative Risks of High-Grade Adverse Events Among FDA-Approved Systemic Therapies in Advanced Melanoma: Systematic Review and Network Meta-Analysis.docx
Background: Head-to-head evidence is lacking in comparative risks of high-grade adverse events (AEs) among different systemic treatment options for advanced melanoma. Methods: An up-to-date systematic
NIAID Data Ecosystem40
Laboratory adverse events for the AP-only analysis group.
Laboratory adverse events for the AP-only analysis group.
NIAID Data Ecosystem30
Disproportionality Analysis of Fondaparinux-Associated Adverse Events Based on the FDA Adverse Event Reporting System (FAERS)
This dataset contains the minimal underlying data used to reproduce the findings of the study titled “Safety profile of fondaparinux based on the FAERS database: a disproportionality analysis”. The da
DataCite Commons2025-11-16 更新50
Top 30 PTs by number of reported cases.
The aim of this study was to investigate frequencies, types, and signals of adverse drug events (ADEs) associated with sodium zirconium cyclosilicate (SZC) used for the treatment of hyperkalemia, in o
NIAID Data Ecosystem30
